Alan Baik, MD

Title(s)HS Clinical Instructor, Medicine
SchoolSchool of Medicine
Address555 Mission Bay Blvd South
San Francisco CA 94158
Phone415-476-1528
ORCID ORCID Icon0000-0001-8840-8825 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard College, Cambridge, MA AB05/2008Biology
    University of California, San Francisco, San Francisco, CAMD06/2014Medicine
    University of California, San Francisco, San Francisco, CA06/2017Internal Medicine
    University of California, San Francisco, San Francisco, CA 06/2021Cardiovascular Medicine
    Collapse Awards and Honors
    2011  - 2012Sarnoff Cardiovascular Research Fellowship (1st Year Fellow)
    2012  - 2013Sarnoff Cardiovascular Research Fellowship (2nd Year Fellow)
    2014UCSF Dean's Award in Molecular Medicine
    2021Chan-Zuckerberg Biohub Physician-Scientist Fellow
    2021  - 2023Sarnoff Scholar Award

    Collapse Overview 
    Collapse Overview
    I am a cardiologist with an expertise in cardio-oncology. Cardio-oncology is an emerging field in cardiovascular medicine that is focused on the cardiovascular care of cancer patients and survivors who have developed cardiovascular disease from their cancer-directed therapies. These therapies include traditional chemotherapy, immunotherapy, targeted therapy, and radiation therapy, among others. Cancer patients are at increased risk of cardiovascular disease, and this can be further exacerbated by their cancer-directed therapies, which can cause a myriad of cardiovascular problems, such as cardiomyopathy, heart failure, arrhythmias, hypertension, pericardial disease, valvular disease, and metabolic syndrome. I work closely with oncologists and other providers in a multidisciplinary team to optimize the cardiovascular care of cancer patients.

    I am also a physician-scientist with a research focus on how cells, tissues, and organisms respond and adapt to low oxygen (hypoxia) and high oxygen (hyperoxia) states. I am studying novel ways cells and tissues respond to states of low oxygen and why high oxygen is toxic at the cellular and systemic levels.

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol. 2021 Jul 07. Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ. PMID: 34232253.
      View in: PubMed   Mentions:    Fields:    
    2. Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circ Res. 2021 May 28; 128(11):1780-1801. Baik AH, Oluwole OO, Johnson DB, Shah N, Salem JE, Tsai KK, Moslehi JJ. PMID: 33934609.
      View in: PubMed   Mentions:    Fields:    
    3. Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. Circ Res. 2021 Jun 25; 129(1):e21-e34. Asnani A, Moslehi JJ, Adhikari BB, Baik AH, Beyer AM, de Boer RA, Ghigo A, Grumbach IM, Jain S, Zhu H, American Heart Association Council on Basic Cardiovascular Sciences; Cardio-Oncology Science Subcomm . PMID: 33934611.
      View in: PubMed   Mentions: 2     Fields:    
    4. Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors. Clin Sci (Lond). 2021 03 12; 135(5):703-724. Baik AH, Tsai KK, Oh DY, Aras MA. PMID: 33686402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Abstract 14843: Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Associated Myocarditis. Circulation. 2020 Nov 17; 142(Suppl_3). John R Power, Joachim Alexandre, Arrush Choudhary, benay ozbay, Nicolas L Palaskas, Lorenz H Lehmann, Daniel Finke, Jennifer Cautela, Franck Thuny, Yuichi Tamura, Salim S Hayek, Tariq U Azam, Aarti Asnani, Tyler Mehegan, Mandar A Aras, Alan H Baik, Lauren Gilstrap, Michal Laufer-Perl, Dimitri Arangalage, Steven Ewer, Matthew Martini, Joseph Nowatzke, Olusola A Orimoloye, Douglas M Brinkley, Wouter C Meijers, Charlotte Fenioux, Stephane EDERHY, Javid J Moslehi, Joe-elie Salem. .
      View in: Publisher Site   Mentions:
    6. Abstract 15365: Natural History of Immune Checkpoint Inhibitor Associated Myocarditis With Preserved Ejection Fraction. Circulation. 2020 Nov 17; 142(Suppl_3). Joseph Nowatzke, John R Power, Wouter C Meijers, Olusola Orimoloye, Charlotte Fenioux, Yuichi Tamura, Jennifer Cautela, Lorenz H Lehmann, Daniel Finke, Salim Hayek, Tariq U Azam, Aarti Asnani, Tyler Mehegan, Alison Weppler, Alan H Baik, Mandar A Aras, Anna Narezkina, Dimitri Arangalage, fanny rocher, Gerard Alexandre, Nicolas L Palaskas, Joe-elie Salem, Javid Moslehi. .
      View in: Publisher Site   Mentions:
    7. Turning the Oxygen Dial: Balancing the Highs and Lows. Trends Cell Biol. 2020 07; 30(7):516-536. Baik AH, Jain IH. PMID: 32386878.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. Cell. 2016 Apr 07; 165(2):497. Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG. PMID: 27058668.
      View in: PubMed   Mentions: 10     Fields:    
    9. EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. Cell. 2016 Feb 25; 164(5):884-95. Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG. PMID: 26919427.
      View in: PubMed   Mentions: 37     Fields:    Translation:Animals
    10. ACUTE HYPOXIA-INDUCIBLE FACTOR EGLN1 INACTIVATION PROTECTS AGAINST ISCHEMIA-REPERFUSION INJURY BY REGULATION OF GLUCOSE OXIDATION AND REACTIVE OXYGEN SPECIES GENERATION. Journal of the American College of Cardiology. 2013 Mar 1; 61(10):e28. Alan Baik, Ben Olenchock, Javid Moslehi, William G. Kaelin. .
      View in: Publisher Site   Mentions:
    11. Genetic subdivision of chemosynthetic endosymbionts of Solemya velum along the Southern New England coast. Appl Environ Microbiol. 2009 Sep; 75(18):6005-7. Stewart FJ, Baik AH, Cavanaugh CM. PMID: 19633116.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    Alan's Networks
    Concepts (33)
    Derived automatically from this person's publications.
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _